Life Science Nation Newsletter  |  April 30, 2015  |  Issue 109

  The LSN Story   |   Investor Platform   |   Company Platform   |   RESI Conference   |   Fundraising Accelerator
Life Science Investor Mandates (Apr. 23 - Apr. 29)

Looking Opportunistically in the Life Science Space

Seeking to Invest in Healthcare IT and Imaging Technologies

Seeking Early Stage Oncology Therapeutics
Seeking Therapeutics Devices and Diagnostics Across the United States
In This Issue

If You Build It, They Will Come! 


Q1 2015 Life Science Financing Roundup

RESI @ TMCx "Healthcare IT Investors" Panel Announcement

RESI Conference Group's Upcoming Events
LSN Videos
RESI 4 Recap Video, San Francisco, 2015
RESI 4 Investor Panel Videos
 Fundraising Boot Camp
By Dennis Ford, Founder & CEO, LSN

The list below represents the investors who are currently confirmed to attend the RESI @ TMCx conference this June 8th in Houston. This number can be expected to double during the final month leading up to the event. Whether you are just thinking of raising capital in the life science space or have actively begun the process, the RESI conference offers a one-of-a-kind opportunity to get some feedback and build relationships with the investors in your market...



Click the image to find out more confirmed investors
Q1 2015 Life Science Financing Roundup

By Lucy Parkinson, Senior Research Manager, LSN 


It's been an exciting Q1 for the biotech industry, with the PwC MoneyTree Report recording 193 biotech and medtech venture financing deals. The LSN Company Platform tracks life science financing events more broadly than the MoneyTree Report; in addition to venture financing rounds, the platform also records other forms of financing secured by the 30,000 biotech and medtech companies tracked, including debt financing, research grants, IPOs, and post-IPO offerings. This is useful information if you're providing services in the life science sector and need to know your customers' capital landscape. The platform also records the lead investor and any co-investors in each financing event.

It may be months before all the deals that took place in Q1 are formally announced and accounted for, but at present the LSN Company Platform has recorded 229 life science financing events that took place in Q1 2015. These financings raised a total of almost $10 billion, buoyed by huge late stage private rounds and follow-on public offerings. Among the financing events LSN tracked, the median amount raised was $15 million. Figure 1 provides a complete breakdown of the amount raised by the financing events recorded in Q1:..

RESI @ TMCx "Healthcare IT Investors" Panel Announcement

By Natasha Eldridge, Marketing Manager, Life Science Nation 


The healthcare IT sector is booming, with $6.5 billion invested in healthcare IT companies in 2014. As the Texas Medical Center taking a lead on supporting healthcare IT companies in the Southwest, RESI @ TMCx will feature a panel session exploring investment in the sector.


LSN has gathered a group of experienced healthcare IT investors to share their expertise and advice with entrepreneurs.  These investors focus on the information technology opportunities that underlie healthcare innovation, from the possibilities created by big data to the digitization of healthcare providers and research labs.  Panelists will discuss issues related to funding in healthcare IT, such as: How do you make your company stand out in this crowded marketplace?  What do investors see as the most high-potential fields of innovation in healthcare IT?  How do you demonstrate to an investor that your product has the potential to succeed?


Joining the moderator, David Franklin, Managing Director, Houston Health Ventures will be: 

  • Eugene Zhang, Founding Partner, TEEC Angel Fund
  • Michael Peck, Venture Partner, Flyover Capital
  • Momei Qu, Senior Associate, Baird Capital
  • Tom Hawes, Managing Director, Sandbox Industries